Ondansetron Orally Disintegrating tablets USP 8 mg. 2. Qualitative and quantitative composition: Each Uncoated tablet contains: Ondansetron USP 8 mg.
Each 4-mg Ondansetron Orally Disintegrating Tablet, USP for oral administration contains 4 mg ondansetron base. Each 8-mg Ondansetron Orally Disintegrating Tablet
ZOFRAN. ODT. (Oral Disintegrating Tablets). (ondansetron). 4 mg and 8 mg ondansetron orally disintegrating tablets, USP. Antiemetic. (5-HT3
Ondansetron Hydrochloride Tablets and Ondansetron Orally Ondansetron Orally Disintegrating Tablets (ODT) USP, 4 mg and 8 mg.
ZOFRAN. ODT. (Oral Disintegrating Tablets). (ondansetron). 4 mg and 8 mg ondansetron orally disintegrating tablets, USP. Antiemetic. (5-HT3
ZOFRAN. ODT. (Oral Disintegrating Tablets). (ondansetron). 4 mg and 8 mg ondansetron orally disintegrating tablets, USP. Antiemetic. (5-HT3
The recommended oral dosage is one 8-mg ondansetron tablet USP or one 8-mg ondansetron orally disintegrating tablet USP given 3 times a day. For total body irradiation, one 8-mg ondansetron tablet USP or one 8-mg ondansetron orally disintegrating tablet USP should be administered 1 to 2 hours before each fraction of radiotherapy administered
Ondansetron Orally Disintegrating tablets USP 8 mg. 2. Qualitative and quantitative composition: Each Uncoated tablet contains: Ondansetron USP 8 mg.
ZOFRAN. ODT. (Oral Disintegrating Tablets). (ondansetron). 4 mg and 8 mg ondansetron orally disintegrating tablets, USP. Antiemetic. (5-HT3
Comments
MG